Elevance Health (WBO:ELV) Interest Expense: €-1,216 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ELV Elevance Health Inc WBO:ELV
84 GF Score
Price €340.80
GF Value €443.34
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Elevance Health Interest Expense?

Elevance Health WBO:ELV -8.14% 84 Interest Expense is €-1,216 Mil as of Mar. 2026. GuruFocus rates WBO:ELV with a GF Score™ of 84/100 and a GF Value™ of €443.34 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Elevance Health's interest expense for the three months ended in Mar. 2026 was € -309 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-1,216 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Elevance Health's Operating Income for the three months ended in Mar. 2026 was € 2,302 Mil. Elevance Health's Interest Expense for the three months ended in Mar. 2026 was € -309 Mil. Elevance Health's Interest Coverage for the quarter that ended in Mar. 2026 was 7.45. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elevance Health  (WBO:ELV) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elevance Health's Interest Expense for the three months ended in Mar. 2026 was €-309 Mil. Its EBIT for the three months ended in Mar. 2026 was €2,302 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €26,614 Mil.

Elevance Health's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* EBIT (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*2301.765/-308.805
=7.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Elevance Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Elevance Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Interest Expense Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -706.23 -803.34 -944.51 -1,131.68 -1,197.31

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -318.20 -295.65 -299.05 -312.56 -308.81
WBO:ELV
84GF Score
Elevance Health Inc WBO:ELV
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,216 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-1,216 Mil mean?
Elevance Health (WBO:ELV) has a Interest Expense of €-1,216 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elevance Health and its competitors.
Is Elevance Health's Interest Expense too high?
Elevance Health's current Interest Expense is €-1,216 Mil. Overall, Elevance Health has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Interest Expense compare to CI and HUM?
Elevance Health's Interest Expense of €-1,216 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Plans company?
A good Interest Expense depends on the Healthcare Plans industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elevance Health and its competitors. Elevance Health's current Interest Expense is €-1,216 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €443.34, compared to a current price of €340.80 — trading 23.1% below its estimated fair value. The current Interest Expense is €-1,216 Mil. Elevance Health's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current Interest Expense is €-1,216 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (WBO:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €340.80 is trading 23.1% below its estimated GF Value™ of €443.34. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for WBO:ELV:

  • Interest Expense: €-1,216 Mil
  • GF Value™: €443.34 vs. price of €340.80 (23.1% below fair value)
  • GF Score™: 84/100 with 8 warning signs

No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
84GF Score

Get the complete analysis for WBO:ELV

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€340.80
Price
€443.34
GF Value